MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients

A. Guekht, M. Lebedeva, G. Popov, A. Yakovlev, O. Davidov (Moscow, Russian Federation)

Meeting: 2017 International Congress

Abstract Number: 65

Keywords: Autonomic dysfunction, Cognitive dysfunction, Depression

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: The aim of the study was to determine the relationship between depression, cognitive disorders and autonomic regulation of the cardiovascular system in patients with PD.

Background: Autonomic dysfunction and cognitive disorders are an integral part of the PD, as well as depression is often associated with PD, although the interdependence of these conditions is not well studied.

Methods: 47 patients (mean age 65.8±1.7; 17M/30F) with PD were compared to 28 healthy age and gender-matched controls. Cognition was evaluated using Mini-mental State Examination (MMSE) and Frontal Assessment Battery (FAB). Depression was assessed by Hamilton Depression Rating Scale (HDRS). The heart rate variability (HRV) and blood pressure variability (BPV) was analyzed in time- and frequency-domains. The spectral total power (TP), low frequency (LF) and high frequency (HF) bands and the ratio between LF/HF were calculated. Spontaneous baroreflex sensitivity (BRS) was computed by spectral analysis from R-R time series based on functional testing with slow deep breathing.

Results: The distribution of patients with PD by stages is shown in the Table 1. MMSE (25.3±2.8) and FAB (14.8±3.3) score showed mild cognitive impairment in patients with PD. HDRS score (17.5±4.3) reflects moderate depression in the studied PD group. Resting HR was significantly higher in PD compared to controls. Significant decrease was observed in key HRV parameters (TP, LF, HF, SDNN) and BRS values (Table 2). Statistical analysis revealed no significant differences in indicators of autonomic regulation of the cardiovascular system in patients at different stages of PD by Hoehn and Yahr. It has been found that the higher HDRS score in PD patients was associated with more significant decrease in LF band for HRV (p=0.01) and systolic BPV (p=0.031) reflecting autonomic balance shift towards parasympathetic domination. More significant cognitive impairment was associated with a marked reduction of TP and SDNN and decrease in value of LF and LF/HF (p=0.02, r=0.4; p=0.04, r=0.5; p=0.005, r=0.5; p=0.02, r=0.4, respectively).

Conclusions: These findings support the view that progressive noradrenergic denervation underlies both cardiovascular autonomic dysfunction and cognitive impairment. Depression also might be associated with functional impairment of the autonomic nervous system and both have common pathologic substrate in PD patients.

To cite this abstract in AMA style:

A. Guekht, M. Lebedeva, G. Popov, A. Yakovlev, O. Davidov. Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/cardiovascular-autonomic-dysfunction-depression-and-cognitive-disorders-in-parkinsons-disease-patients/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cardiovascular-autonomic-dysfunction-depression-and-cognitive-disorders-in-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley